A Collaborative Agenda-Setting Intervention (CASI) for the Improvement of Communication and Health-Related Quality of Life in Advanced or Recurrent Ovarian Cancer Patients
This clinical trial studies whether a collaborative agenda-setting intervention (CASI) improves communication and health-related quality of life in patients with ovarian cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has come back after a period of improvement (recurrent). Treatment for advanced ovarian cancer may include complex surgery followed by combination chemotherapy. This treatment approach may lead to the patient experiencing poor health-related quality of life due to several side effects or mental distress. Patient-centered communication is an approach that can improve health-related quality of life. The CASI promotes patient-centered communication by agenda-setting. Agenda-setting is a process that allows clinicians, patients, and caregivers to align themselves on what will be discussed at a visit. The CASI assists patients and caregivers in setting the visit agenda by prompting them to state their communication preferences and identify their concerns in the patient portal prior to a scheduled clinic visit. Once the CASI is completed clinicians can offer educational materials to the patient based on responses to the CASI. The CASI may be an effective communication tool for advanced or recurrent ovarian cancer patients, which may improve their health-related quality of life.